Document:

Exhibit 10.3

 

SECOND AMENDMENT TO

SERIES A PREFERRED STOCK PURCHASE AGREEMENT

 

This SECOND AMENDMENT
TO SERIES A PREFERRED STOCK PURCHASE AGREEMENT (the “Amendment”) is made and entered into as of September 9,
2019, by and between Allied Physicians of California, a Professional Medical Corporation, a California corporation (the “Company”
or “Seller”), and AP-AMH Medical Corporation, a California professional medical corporation (“Buyer”).

 

A.           Seller
and Buyer have previously entered into that certain Series A Preferred Stock Purchase Agreement dated as of May 10, 2019, as amended
by that certain First Amendment to Series A Stock Purchase Agreement dated as of August 26, 2019 (together, the “Preferred
Stock Purchase Agreement”).

 

B.           Seller
and Buyer desire to further amend the Preferred Stock Purchase Agreement as set forth herein.

 

NOW, THEREFORE, in
consideration of the premises and of the mutual agreements, representations, warranties, provisions and covenants herein contained,
the parties hereto, each intending to be bound hereby, agree as follows:

 

1.          Definitions.
Capitalized terms used but not defined in this Amendment shall have the meanings given to such terms in the Preferred Stock Purchase
Agreement.

 

2.          Definition
of Excluded Assets. Exhibit A to the Preferred Stock Purchase Agreement is hereby amended by amending and restating the definition
of “Excluded Assets” in Section 1 thereof to read in full as follows:

 

“Excluded
Assets” means (i) assets received from the sale of shares of the Series A Preferred equal to the Series A Purchase Price,
(ii) the assets of the Company that are not Healthcare Services Assets, including the Company’s equity interests in
Universal Care, Inc., Apollo Medical Holdings, Inc., and any entity that is primarily engaged in the business of owning, leasing,
developing or otherwise operating real estate, (iii) any assets acquired with the proceeds of the sale, assignment or other
disposition of any of the assets described in clauses (i) or (ii), and (iv) any proceeds of the assets described in clauses
(i), (ii) and (iii).

 

3.          Effect
of Amendment. Except as expressly amended by this Amendment, all of the terms of the Preferred Stock Purchase Agreement shall
remain unchanged and in full force and effect. The provisions of Article X of the Preferred Stock Purchase Agreement are incorporated
in this Amendment by this reference, mutatis mutandis.

 

[Signatures appear on the following page.]

 

    1

     

    

 

IN WITNESS WHEREOF,
this Amendment has been executed as of the date first above written.

 

	 	BUYER:
	 	 
	 	AP-AMH MEDICAL CORPORATION
	 	 
	 	By:	/s/ Thomas Lam                 
	 	Name: 	Thomas Lam, M.D.
	 	Title:	Chief Executive Officer
	 	 
	 	SELLER:
	 	 
	 	ALLIED PHYSICIANS OF CALIFORNIA, 
	 	A PROFESSIONAL MEDICAL CORPORATION
	 	 
	 	By:	/s/ Terry Lee, M.D.
	 	Name:	Terry Lee, M.D.
	 	Title:	Independent Committee Director

 

    S-1Exhibit 10.4

 

FIRST AMENDMENT TO

SPECIAL PURPOSE SHAREHOLDER AGREEMENT

 

OF

 

ALLIED PHYSICIANS OF CALIFORNIA,

 

A PROFESSIONAL MEDICAL CORPORATION

 

This FIRST AMENDMENT
TO SPECIAL PURPOSE SHAREHOLDER AGREEMENT (the “Amendment”) is made and entered into as of September 11, 2019,
MEDICAL CORPORATION doing business as Allied Pacific of California IPA (the “Corporation”), and AP-AMH
MEDICAL CORPORATION, a California professional medical corporation, the holder of the Series A Preferred Stock (the “Series
A Preferred Stockholder”).

 

A.           The
Corporation and the Series A Preferred Stockholder have previously entered into that certain Special Purpose Shareholder Agreement
dated as of May 10, 2019 (the “Shareholder Agreement”).

 

B.           The
Corporation and the Series A Preferred Stockholder desire to amend the Shareholder Agreement as set forth herein.

 

NOW, THEREFORE, in
consideration of the premises and of the mutual agreements, representations, warranties, provisions and covenants herein contained,
the parties hereto, each intending to be bound hereby, agree as follows:

 

1.          Definitions.
Capitalized terms used but not defined in this Amendment shall have the meanings given to such terms in the Shareholder Agreement.

 

2.          Recital
A. Recital A of the Shareholder Agreement is hereby amended and restated in its entirety as follows:

 

A.           The
Corporation will issue 1,000,000 shares of Series A Preferred Stock to the Series A Preferred Stockholder pursuant to the Certificate
of Determination of Preferences of Series A Preferred Stock of Allied Physicians of California, A Professional Medical Corporation,
dated September 11, 2019, a copy of which is attached as Exhibit A hereto (the “Certificate of Determination”).

 

3.          Exhibit
A. Exhibit A to the Shareholder Agreement is hereby amended and restated in its entirety as set forth on Attachment 1
to this Amendment.

 

4.          Effect
of Amendment. Except as expressly amended by this Amendment, all of the terms of the Shareholder Agreement shall remain unchanged
and in full force and effect. The provisions of Article II of the Shareholder Agreement are incorporated in this Amendment by this
reference, mutatis mutandis.

 

[Signatures appear on the following page.]

 

    1

     

    

 

IN WITNESS WHEREOF,
this Amendment has been executed as of the date first above written.

 

	“Corporation”:	 	“Series A Preferred Stockholder”:
	 	 	 
	ALLIED PHYSICIANS OF CALIFORNIA,  A PROFESSIONAL MEDICAL CORPORATION	 	AP-AMH MEDICAL CORPORATION
	 	 	 
	By:	/s/ Terry Lee, M.D.	 	By:	/s/ Thomas Lam
	Name: 	Terry Lee, M.D.	 	Name: 	Thomas Lam, M.D.
	Title:	Independent Committee Member	 	Title:	Chief Executive Officer

 

    S-1Exhibit 10.5

 

FIRST AMENDMENT TO

TRADENAME LICENSING AGREEMENT

 

This FIRST AMENDMENT
TO TRADENAME LICENSING AGREEMENT (this “Amendment”) is made and entered into as of September 10, 2019, by and
between Apollo Medical Holdings, Inc., a Delaware corporation (“Apollo”), and AP-AMH Medical Corporation, a
California professional medical corporation ("AP-AMH").

 

A.           Apollo
and AP-AMH have previously entered into that certain Tradename Licensing Agreement dated as of May 10, 2019 (the “Agreement”).

 

B.           Apollo
and AP-AMH desire to amend the Agreement as set forth herein.

 

NOW, THEREFORE, in
consideration of the premises and of the mutual agreements, representations, warranties, provisions and covenants herein contained,
the parties hereto, each intending to be bound hereby, agree as follows:

 

1.    
      Definitions. Capitalized terms used but not defined in this Amendment shall have
the meanings given to such terms in the Agreement.

 

2.     
     Section 2. The following is hereby added at the end of Section 2 of the Agreement:

 

“To the extent that AP-AMH
is unable to pay any Tradename License Fee when due hereunder because it has received Series A Dividends in an amount insufficient
(or because it has not received any Series A Dividends) to pay in full such Tradename License Fee, such unpaid Tradename License
Fee(s) shall accrue and be paid upon receipt by AP-AMH of sufficient funds.”

 

3.      
    Section 3.3.1. Section 3.3.1 of the Agreement is hereby amended and restated in its entirety
as follows:

 

3.3.1        Immediately
upon termination of the Tradename License, (i) AP-AMH shall cease using the name “Apollo Medical Associates” and every
variation and portion of it, in every respect (including but not limited to signage), and AP-AMH shall not make any reference on
its letterhead or other materials to its former or then current affiliation with Apollo or its former license or use of said name;
and (ii) AP-AMH shall cause to be filed with the California Medical Board a cancellation of the fictitious name permit issued to
AP-AMH for the name “Apollo Medical Associates,” which cancellation shall be in form and substance acceptable to Apollo.

 

4.   
       Schedule 1. Schedule 1 to the Agreement (Tradename License Fee Percentage)
is hereby amended and restated in its entirety as set forth in Exhibit A to this Amendment.

 

5.    
      Effect of Amendment. Except as expressly amended by this Amendment, all of the
terms of the Agreement shall remain unchanged and in full force and effect.

 

    - 1 -

     

    

 

IN WITNESS WHEREOF,
this Amendment has been executed as of the date first above written.

 

	“Apollo”	 	“AP-AMH”
	 	 	 
	APOLLO MEDICAL HOLDINGS, INC.	 	AP-AMH MEDICAL CORPORATION
	 	 	 
	By:	/s/ Mitchell Kitayama	 	By:	/s/ Thomas Lam
	 	Mitchell Kitayama	 	 	Thomas S. Lam, M.D.,
	 	Independent Committee Director	 	 	Chief Executive Officer
	 	 	 
	By:	/s/ Eric Chin          	 	 
	 	Eric Chin	 	 
	 	Chief Financial Officer	 	 

 

Signature Page to

FIRST AMENDMENT TO TRADENAME LICENSING
AGREEMENTExhibit 10.6

 

FIRST AMENDMENT TO

ADMINISTRATIVE SERVICES AGREEMENT

 

This FIRST AMENDMENT
TO ADMINISTRATIVE SERVICES AGREEMENT (this “Amendment”) is made and entered into as of September 10, 2019, by
and between Network Medical Management, Inc., a California corporation (“Manager”), and AP-AMH Medical Corporation,
a California professional medical corporation ("AP-AMH").

 

A.           Manager
and AP-AMH have previously entered into that certain Administrative Services Agreement dated as of May 10, 2019 (the “Agreement”).

 

B.           Manager
and AP-AMH desire to amend the Agreement as set forth herein.

 

NOW, THEREFORE, in
consideration of the premises and of the mutual agreements, representations, warranties, provisions and covenants herein contained,
the parties hereto, each intending to be bound hereby, agree as follows:

 

1.     
     Definitions. Capitalized terms used but not defined in this Amendment shall have the
meanings given to such terms in the Agreement.

 

2.      
    Section 2.1. The following is hereby added at the end of Section 2.1 of the Agreement:

 

“To the extent
that AP-AMH is unable to pay any Administrative Fee when due hereunder because it has received Series A Dividends in an
amount insufficient (or because it has not received any Series A Dividends) to pay in full such Administrative Fee, such
unpaid Administrative Fee(s) shall accrue and be paid upon receipt by AP-AMH of sufficient funds.”

 

3.     
     Schedule 1. Schedule 1 to the Agreement (Administrative Fee Percentage) is hereby
amended and restated in its entirety as set forth in Exhibit A to this Amendment.

 

4.    
      Effect of Amendment. Except as expressly amended by this Amendment, all of the
terms of the Agreement shall remain unchanged and in full force and effect.

 

[Signatures appear on the following page.]

 

    - 1 -

     

    

 

IN WITNESS WHEREOF,
this Amendment has been executed as of the date first above written.

 

	“Manager”	 	“AP-AMH”
	 	 	 
	NETWORK MEDICAL MANAGEMENT, INC.	 	AP-AMH MEDICAL CORPORATION
	 	 	 
	By:  	/s/ Eric Chin	 	By: 	/s/ Thomas Lam
	 	Eric Chin	 	 	Thomas S. Lam, M.D.,
	 	Chief Financial Officer	 	 	Chief Executive Officer

 

Signature Page to

FIRST AMENDMENT TO ADMINISTRATIVE SERVICES
AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]